Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma

BACKGROUND: CD86 has great potential to be a new target of immunotherapy by regulating cancer immune response. However, it remains unclear whether CD86 is a friend or foe in lower-grade glioma (LGG). METHODS: The prognostic value of CD86 expression in pan-cancer was analyzed using Cox regression and...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Oncol
Prif Awduron: Qiu, Huaide, Tian, Wei, He, Yikang, Li, Jiahui, He, Chuan, Li, Yongqiang, Liu, Ning, Li, Jianan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2021
Pynciau:
Oncology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089378/
https://ncbi.nlm.nih.gov/pubmed/33954112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.654350
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg